LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma (ALCI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00062868
Recruitment Status : Active, not recruiting
First Posted : June 18, 2003
Last Update Posted : July 4, 2018
Texas Children's Hospital
The Methodist Hospital System
Center for Cell and Gene Therapy, Baylor College of Medicine
Information provided by (Responsible Party):
Helen Heslop, Baylor College of Medicine

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : April 2014
  Estimated Study Completion Date : January 2020
Publications automatically indexed to this study by Identifier (NCT Number):